# A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour

> **NCT00778128** · PHASE1 · COMPLETED · sponsor: **Clavis Pharma** · enrollment: 26 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** CP-4126
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00778128
- **Lead sponsor:** Clavis Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2010-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00778128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00778128, "A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00778128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*